AbelingNGGMRuschHvan GennipAH: 1996, Improved selectivity of urinary oligosaccharide screening using two one-dimensional TLC systems. J Inher Metab Dis19:260–262.
2.
AlroyJDe GasperiRWarrenCD: 1991, Application of lectin histochemistry and carbohydrate analysis to the characterization of lysosomal diseases. Carbohydr Res213:229–250.
3.
AlroyJFredenGOGoyalV: 1989, Morphology of leukocytes from cats affected with α-mannosidosis and mucopolysaccharidosis VI (MPS VI). Vet Pathol26:294–302.
4.
AlroyJHaskinsMBirkDE: 1999, Altered corneal matrix organization is associated with mucopolysaccharidosis I, III and VI. Exp Eye Res68:523–530.
AlroyJOrgadUDeGasperiR: 1992, Canine GM1-gangliosidosis: a clinical, morphologic, histochemical, and biochemical comparison of two different models. Am J Pathol140:675–689.
7.
AlroyJOrgadUUcciAAGravisVE: 1985, Swainsonine toxicosis mimics lectin histochemistry of mannosidosis. Vet Pathol22:311–316.
8.
AlroyJOrgadUUcciAAPereiraMEA: 1984, Identification of glycoprotein storage diseases by lectins. A new diagnostic method. J Histochem Cytochem32:1280–1284.
9.
AlroyJSchunkKLRaghavanSS: 1988, Alpha-mannosidase deficiency in Persian cats: a model of human alphamannosidosis. In: Lipid storage disorders: biological and medical aspects, eds. SalvayreRDouste-BlazeLGattS, pp. 649–659. Plenum, New York, NY.
10.
AlroyJUcciAAGoyalVWoodsW: 1986, Lectin histochemistry of glycolipid storage diseases on frozen and paraffin-embedded tissue sections. J Histochem Cytochem34:501–505.
11.
AlroyJWarrenCDRaghavanSS: 1987, Biochemical, ultrastructural and histochemical studies of cat placentae deficient in activity of lysosomal α-mannosidase. Placenta8:545–553.
12.
BargalRBachG: 1997, Mucolipidosis type IV: abnormal transport of lipid to lysosomes. J Inher Metab Dis20:625–632.
13.
BaronRNeffLLouvardDCourtoyPJ: 1985, Cell-mediated extracellular acidification and bone resorption: evidence for low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol101:2210–2222.
14.
BaroneRCarchonHJansenE: 1998, Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency). J Inher Metab Dis21:167–172.
15.
BergTTollersrudOKWalkleySU: 1997, Purification of feline lysosomal α-mannosidase, determination of its cDNA sequence and identification of a mutation causing α-mannosidosis in Persian cats. Biochem J328:863–870.
16.
BermudezAJJohnsonGCVanierMT: 1995, Gangliosidosis in emu (Dromaius novaehollandiae). Avian Dis39: 292–303.
17.
BerryHK: 1987, Screening for mucopolysaccharide disorders with the Berry spot test. Clin Biochem20:365–371.
BeutlerEGrabowskiGA: 1995, Gaucher disease. In: The metabolic and molecular basis of inherited diseases, eds. ScriverCRBeaudetALSlyWSValleD, 7th ed., vol. 2, pp. 2641–2670. McGraw Hill, New York, NY.
20.
BungeSSteglichCLorenzP: 1994, Prenatal diagnosis and carrier detection in mucopolysaccharidosis type II by mutation analysis. A 47, XY male heterozygous for a missense point mutation. Prenatal Diag14:777–780.
21.
ByersSRozaklisTBrumfieldLK: 1998, Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Mol Genet Metabol65:282–290.
22.
CastagnaroMAlroyJUcciAAGlewRH: 1987, Lectin histochemistry and ultrastructure of feline kidneys from six different storage diseases. Virchows Arch B Cell Pathol54:16–26.
23.
CavanaghKTLeipprandtJRJonesMZFridericiK: 1995, Molecular defect of caprine N-acetylglucosamine-6-sulphatase deficiency. A single base substitution creates a stop codon in the 5′-region of the coding sequence. J Inher Metab Dis18: 96.
24.
ChenC-SBachGPaganoRE: 1998, Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci USA95:6373–6378.
25.
CorkLCMunnellJFLorenzMD: 1978, The pathology of feline GM2 gangliosidosis. Am J Pathol90:723–734.
26.
CummingsJFWoodPAde LahuntaA: 1988, The clinical and pathologic heterogeneity of feline alpha-mannosidosis. J Vet Intern Med2:163–170.
27.
CummingsJFWoodPAWalkleySU: 1985, GM2-gangliosidosis in a Japanese Spaniel. Acta Neuropathol67:247–253.
28.
DahlDLWarrenCDRathkeEJSJonesMZ: 1986, β-mannosidosis: prenatal detection of caprine allantoic fluid oligosaccharides with thin layer, gel permeation and high performance liquid chromatography. J Inher Metab Dis9:93–98.
29.
d'AzzoAAndriaGStrisciuglioPGaljaardH: 1995, Galactosialidosis. In: The metabolic and molecular basis of inherited diseases, eds. ScriverCRBeaudetALSlyWSValleD, 7th ed., vol. 2, pp. 2825–2837. McGraw Hill, New York, NY.
30.
DorlingPR: 1984, Lysosomal storage diseases in animals. In: Lysosomes in biology and pathology, eds. DingleJTDeanRTSlyW, pp. 347–379. Elsevier, Amsterdam, The Netherlands.
31.
FernandesMJGHechtmanPBoulayBKaplanF: 1997, A chronic GM2 gangliosidosis variant with HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts. Eur J Hum Genet5:129–136.
32.
FujimuraHOguraAAsanoT: 1996, Lysosomal glycolipid storage in renal tubular epithelium in mastomys (Praomys coucha). Histol Histopathol11:171–174.
33.
FyfeJCKurzhalsRLGigerU: 1996, Missense mutation causes beta-glucuronidase deficiency in feline MPS VII. Am J Hum Genet59:A197.
34.
GahlWASchneiderJAAulaPP: 1995, Lysosomal transport disorders: cystinosis and sialic acid storage disorders. In: The metabolic and molecular basis of inherited diseases, eds. ScriverCRBeaudetALSlyWSValleD, 7th ed., vol. 2, pp. 3763–3797. McGraw Hill, New York, NY.
35.
GelbBDShiG-PChapmanHADesnickRJ: 1996, Pycnodysostosis, a lysosomal storage disease caused by cathepsin K deficiency. Science273:1236–1238.
36.
GigerUShivaprasadHWangP: 1997, Mucopolysaccharidosis type IIIB (Sanfilippo B syndrome) in emus. Vet Pathol34:473A.
37.
GiudiciTASunicoHBlaskovicsM: 1996, Diagnostic screening for mucopolysaccharidoses I-VII by fluorophore-labelled carbohydrate PAGE. J Inher Metab Dis19:263–266.
38.
GravelRAClarkeJTRKabackMM: 1995, The GM2 gangliosidoses. In: The metabolic and molecular basis of inherited diseases, eds. ScriverCRBeaudetALSlyWSValleD, pp. 2839–2882, 7th ed., vol. 2. McGraw Hill, New York, NY.
39.
HanichenTBremGSpiessCHermannsW: 1995, Canine lipid storage disease. Eur J Vet Pathol1:37–44.
40.
HannunYABellRM: 1987, Lysosphingolipids inhibit protein kinase C: implications for sphingolipidoses. Science235:670–674.
41.
HansenHGGraucobE: 1985, Hematologic cytology of storage diseases. Springer-Verlag, Berlin, Germany.
42.
HarperPAWWalkerKHHealyPJ: 1988, Neurovisceral ceroid-lipofuscinosis in blind Devon cattle. Acta Neuropathol75:632–636.
43.
HaskinsMGigerU: 1997, Lysosomal storage diseases. In: Clinical biochemistry of domestic animals, eds. KanekoHHarveyJWBrussML, 5th ed., pp. 741–760. AcademicNew York, NY.
44.
HerschkowitzNSchulteJ: 1984, Lipidoses: from defect and dysfunction. Neuropediatrics1(Suppl):110–111.
45.
HolleranWMGinnsEIMenonG: 1994, Epidermal consequence of β-glucocerebrosidase deficiency: permeability barrier alterations and basis for skin lesions in type 2 Gaucher disease. J Clin Invest93:1756–1764.
46.
IshikawaYLiSCWoodPALiYT: 1987, Biochemical basis of type AB GM2-gangliosidosis in a Japanese Spaniel. J Neurochem480:860–864.
47.
JarplidBHaltiaM: 1993, An animal model of the infantile type of neuronal ceroid-lipofuscinosis. J Inher Metab Dis16: 274–277.
JudgeMRAthertonDJSalvayreR: 1994, Neutral lipid storage disease. Case report and lipid studies. Br J Dermatol130:507–510.
52.
KayeMEAlroyJRaghavanSS: 1992, Dysmyelinogenesis in animal model of GM1 gangliosidosis. Pediatr Neurol8:255–261.
53.
KimD-YChoD-YTaylorHW: 1996, Lysosomal storage disease in an emu (Dromaius novaehollandiae). Vet Pathol33: 365–366.
54.
KingNWAlroyJ: 1997, Lysosomal storage diseases. In: Veterinary pathology, eds. JonesTCHuntRDKingNW, pp. 30–50, 6th ed., Williams and Wilkins, Media, PA.
55.
KnowlesKAlroyJCastagnaroM: 1993, Adult-onset lysosomal storage disease in a Schipperke dog: clinical, morphological and biochemical studies. Acta Neuropathol86:306–312.
56.
KolodnyEHFluhartyAL: 1995, Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidoses. In: The metabolic and molecular basis of inherited diseases, eds. ScriverCRBeaudetALSlyWSValleD, 7th ed., vol. 2, pp. 2693–2740. McGraw Hill, New York, NY.
57.
KornfeldSSlyWS: 1995, I-cell disease and pseudo-Hurler polydystrophy: disorders of lysosomal enzyme phosphorylation and localization. In: The metabolic and molecular basis of inherited diseases, eds. ScriverCRBeaudetALSlyWSValleD, 7th ed., vol. 2, pp. 2495–2508. McGraw Hill, New York, NY.
58.
KuniedaTSimonaroCMYoshidaM: 1995, Mucopolysaccharidosis type VI in rats: isolation of cDNA encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation. Genomics29:582–587.
59.
KunitaRNakabayashiOWuJ-Y: 1998, Molecular cloning of acid α-glucosidase cDNA of Japanese quail (Coturnix cotrnix japonica) and the lack of its mRNA in acid maltase deficient quails. Biochem Biophys Acta1362:269–278.
60.
LeinekugelPMichelSConzelmannESandhoffK: 1992, Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet88:513–523.
61.
LeipprandtJRChenHHorvathJE: 1999, Identification of a bovine β-mannosidosis mutation and detection of two β-mannosidase pseudogenes. Mamm Genome10:1137–1141.
62.
LeipprandtJRFridericiKSprecherDJJonesMZ: 1995, Prenatal testing for caprine N-acetylglucosamine-6-sulphatase deficiency and sex identification. J Inher Metab Dis18:647–648.
63.
LeipprandtJRKraemerSAHaithcockBE: 1996, Caprine β-mannosidase: sequencing and characterization of the cDNA and identification of the molecular defect of caprine β-mannosidosis. Genomics37:51–56.
64.
LhotkaJF: 1953, Some histochemical observations on periodic acid-amino-acid mechanisms. Nature171:1123–1124.
65.
LovellKL: 1990, Caprine β-mannosidosis: development of glial and myelin abnormalities in optic nerve and corpus callosum. Glia3:26–32.
66.
LovellKLSprecherDJAmesNKJonesMZ: 1995, Development and efficacy of ultrasound-guided fetal fluid aspiration techniques for prenatal diagnosis of caprine-mannosidosis. Theriogenology44:517–527.
67.
LuziPRafiMAVictoriaT: 1997, Characterization of the Rhesus monkey galactocerebrosidase (GALC) cDNA and gene identification of mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate. Genomics42:319–324.
68.
MaattaAJarvelainenHTNelimarkkaLOPenttinenRP: 1994, Fibroblast expression of collagen and proteoglycans is altered in aspartylglucosaminuria, a lysosomal storage disease. Biochim Biophys Acta1225:264–270.
69.
MenonKPTieuPTNeufeldEF: 1992, Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I. Genomics14:763–768.
70.
MuldoonLLNeuweltEAPagelMAWeissDL: 1994, Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease). Am J Pathol124: 1109–1118.
71.
MullerGBaumgartnerWMoritzA: 1998, Biochemical findings in a breeding colony of Alaskan Huskies suffering from GM1-gangliosidosis. J Inher Metab Dis21:430–431.
72.
MusumeciSD'AgataARomanoC: 1988, Ichthyosis and neutral lipid storage disease. Am J Med Genet29:377–382.
73.
NadelHL: 1973, Acid phosphatase deficiency. In: Lysosomes and storage diseases, eds. HersHGvan HoofF, pp. 475–484. AcademicNew York, NY.
74.
Nanto-SalonenKLarjavaHSaamanenA-MHeinoJ: 1987, Abnormal dermal proteoglycan in aspartyglucosaminuria: a possible mechanism for ultrastructural changes of collagen fibrils in a glycoprotein storage disorder. Connect Tissue Res16:367–376.
75.
Nanto-SalonenKPelliniemiLJAuitoS: 1984, Abnormal collagen fibrils in aspartylglucosaminuria. Altered dermal ultrastructure in a glycoprotein storage disorder. Lab Invest51: 464–468.
76.
NatowiczMRShortMPWangY: 1996, Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med335:1029–1033.
77.
NeufeldEF: 1989, Natural history and inherited disorders of lysosomal enzyme, β-hexosaminidase. J Biol Chem264: 10927–10930.
78.
NeufeldEF: 1991, Lysosomal storage diseases. Annu Rev Biochem60:257–280.
79.
NeuweltEAJohnsonWGBlankNK: 1985, Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats. J Clin Invest76:482–490.
80.
ObeidLMLinardicCMKarolakLAHannunYA: 1993, Programmed cell death induced by ceramide. Science259:1769–1771.
81.
PalmerDNTyynelaJvan MilHC: 1997, Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid-lipofuscinosis. J Inher Metab Dis20:74–84.
82.
PearseAGE: 1961, The plasmal reaction. In: Histochemistry, theoretical and applied, 2nd ed., pp. 347–355. Little, Brown and Company, Boston, MA.
83.
PearseAGE: 1968, Lipids, lipoproteins and proteolipids. In: Histochemistry, theoretical and applied, 2nd ed., vol. 1, pp. 398–446. Little, Brown and Company, Boston, MA.
84.
PearseAGE: 1972, Fluorescene microscopy. In: Histochemistry, theoretical and applied, 3rd ed., vol. 2, pp. 1172–1206. Churchill Livingstone, Edinburgh, Scotland.
85.
PennockCA: 1976, A review and selection of simple laboratory methods used for study of glycosaminoglycan excretion and the diagnosis of the mucopolysaccharidoses. J Clin Pathol29:111–128.
86.
PierceAMLindskogSHammarstromL: 1991, Osteoclasts: structure and function. Electron Microsc Rev4:1–45.
87.
PittoMChigornoVRenlundMTettamantiG: 1996, Impairment of ganglioside metabolism in cultured fibroblasts from Sella patients. Clin Chim Acta247:143–157.
88.
PrasadAKayeEMAlroyJ: 1996, Electron microscopic examination of skin biopsy as a cost effective tool in the diagnosis of lysosomal storage diseases. J Child Neurol11:301–308.
RapolaJ: 1993, Neuronal ceroid-lipofuscinoses in childhood. Prospect Pediatr Pathol17:7–44.
91.
RodriguezMO'BrienJSGarrettRSPowellHC: 1982, Canine GM1-gangliosidosis in dogs with β-galactosidase deficiency. J Neuropathol Exp Neurol41:618–629.
92.
SaftigPHartmannDLullmann-RauchR: 1997, Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system. J Biol Chem272:18628–18635.
93.
SandhoffKHarzerKFurstW: 1995, Sphingolipid activator proteins. In: The metabolic and molecular basis of inherited diseases, eds., ScriverCRBeaudetALSlyWSValleD, 7th ed., vol. 2, pp. 2427–2441. McGraw Hill, New York, NY.
94.
SandsMSBrikenmeierEH: 1993, A single-base-pair deletion in beta-glucuronidase gene account for the phenotype of murine mucopolysaccharidosis type VII. Proc Natl Acad Sci USA90:6567–6571.
95.
SchiffmannRDwyerNKLubenskyIA: 1998, Constitutive achlorhydria in mucolipidosis type IV. Proc Natl Acad Sci USA95:1207–1212.
96.
SchmidtBSelmerTIngendohAvon FiguraK: 1995, A novel amino acid modification in sulfatase that is defective in multiple sulfatase deficiency. Cell82:271–278.
97.
ScriverCRBeaudetALSlyWSValleD, eds.: 1995, Lysosomal enzymes. In: The metabolic and molecular basis of inherited diseases, eds., ScriverCRBeaudetALSlyWSValleD, 7th ed., vol. 2, pp. 2425–2879, 3763–3797. McGraw Hill, New York, NY.
98.
SkellyBJSarganDRHerrtageMEWinchesterBG: 1996, The molecular defect underlying canine fucosidosis. J Med Genet33:284–288.
99.
SkellyBJSarganDRWinchesterBG: 1999, Genomic screening for fucosidosis in English Springer Spaniels. J Vet Res60:726–729.
100.
SuzukiKSuzukiYSuzukiK: 1995, Galactosylceramide lipidosis: globoid-cell leukodystrophy (Krabbe disease). In: The metabolic and molecular basis of inherited diseases, eds. ScriverCRBeaudetALSlyWSValleD, 7th ed., vol. 2, pp. 2671–2692. McGraw Hill, New York, NY.
TaniikeMMarcusJRNishigakiT: 1998, Suppressed UDP-galactose: ceramide galactosyltransferase and myelin protein mRNA in Twitcher mouse brain. J Neurosci Res51: 536–540.
103.
ThompsonJNJonesMZDawsonGHuffmanPS: 1992, N-acetylglucosamine 6-sulphatase deficiency in Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID). J Inher Metab Dis15:760–768.
104.
TollersrudOKBergTHealyPJ: 1997, Purification of bovine lysosomal α-mannosidase, characterization of its gene and determination of two mutations that cause α-mannosidosis. Eur J Biochem246:410–419.
105.
VaananenK: 1996, Osteoclast function. In: Principles of bone biology, eds. BilezikianJPRaiszLGRodanGA, pp. 103–113. Academic, New York, NY.
106.
VictoriaTRafiMAWengerDA: 1996, Cloning of the canine GALC cDNA and identification of the mutation causing Globoid cell leukodystrophy in West Highland White and Cairn Terriers. Genomics33:457–462.
107.
WarrenCDAlroyJBuggeB: 1986, Oligosaccharides from placenta: early diagnosis of feline mannosidosis. FEBS Lett195:247–252.
108.
WarrenCDSadehSDanielPF: 1993, Induced mannosidosis-excretion of oligosaccharides by locoweed-intoxicated sheep. FEBS Lett163:99–103.
109.
WarrenCDSchmitASJeanlozRW: 1983, Chromatographic separation of oligosaccharides from mannosidosis urine. Carbohydr Res116:171–182.
110.
WengerDAWilliamsC: 1991, Screening for lysosomal disorders. In: Techniques in diagnostic human biochemical genetics: a laboratory manual. ed. FristAH, pp. 587–617. Wiley-Liss, New York, NY.